Google's Gemini 3 is live after months of hype. Here's what it can do.

Google has been under pressure to deliver big improvements with its latest AI model. Here are five key Gemini 3 features.

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or ...

Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the ...